WCN26-4477 Far-Infrared Irradiation Improves 12-Month ABI in Hemodialysis Patients: A Single-Center Study

Read full text Summarise with VIRAT
Authors: Masanori Tamaki, Rika Nishioka, Satoshi Nishioka, Masamitsu Sasaki, Kazuhiro Hasegawa, Masaharu Tamaki, Shu Wakino
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

In hemodialysis (HD) patients, peripheral arterial disease (PAD) and lower-limb circulatory impairment worsen survival and quality of life, while options are limited and surgical outcomes are poorer than in the general population. Far-infrared (FIR) irradiation is a bedside-feasible adjunct during HD sessions and has been suggested to improve endothelial function and microcirculation; however, its impact on the ankle–brachial index (ABI) over an annual timescale is unclear. We aimed to estimate the effect of FIR on ABI at 12 months and on the annual change in ABI (ΔABI/year) after adjustment for confounding.

Fields of Study & Subjects

Peripheral Artery Disease Management Infrared Thermography in Medicine Laser Applications in Dentistry and Medicine

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
106163–106163
Publication date
25 March 2026
Language
EN